Cargando…
Case of Anthracycline-induced Cardiogenic Shock: A Call to Optimize Modifiable Cardiac Risk Factors Prior to Chemotherapy
Anthracyclines, including doxorubicin, are an important class of chemotherapeutic agents. Their efficacy, however, is limited by cardiotoxicity. Risk factors for anthracycline-associated cardiotoxicity include dose, treatment-specific risk factors including adjunctive radiotherapy, patient-specific...
Autores principales: | Gabriel, Andre, Stringer, Bryan, Hadfield, Matthew J, Madady, Mona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6726340/ https://www.ncbi.nlm.nih.gov/pubmed/31497415 http://dx.doi.org/10.7759/cureus.4961 |
Ejemplares similares
-
Cardiac Resynchronization Therapy in Cardiogenic Shock: A Case-Based Discussion
por: Somoza-Cano, Francisco J, et al.
Publicado: (2021) -
Cardiogenic Shock: A Rare Complication of Influenza
por: Hashmi, Arsalan Talib, et al.
Publicado: (2018) -
Cardiogenic Shock Induced by Anterior Pituitary Hypofunction and Thyrotoxicosis
por: Li, Lei, et al.
Publicado: (2020) -
Cardiogenic Shock Due to Serotonin Syndrome Induced Takotsubo Cardiomyopathy
por: Yazdi, Vahid, et al.
Publicado: (2023) -
Feasibility of Very Early Identification of Cardiogenic Shock by Semi-automated Ultrasound Exam in the Emergency Department
por: Morales, Gabriel, et al.
Publicado: (2022)